Newsletter
Access and benefit sharing: Ministry of Environment will start to regularize ABS operations on November 6th
ii) Register the sending of samples of Brazilian genetic resources sent for the performance of specific services abroad;
iii) Register the remittance of samples of Brazilian genetic resources;
iv) Notify a final product or reproductive materials;
v) Request authorization to access genetic resources or traditional knowledge in situations when the law demands prior approval of the National Security Council and the Navy;
vi) Request registration of entities that maintain collections with samples of Brazilian genetic resources;
vii) Obtain official documents attesting the registration of ABS, remittance of samples and other notifications;
viii) Obtain certification attesting the status of the proceedings; and
ix) Request certifications attesting the regularity of ABS activities.
Last related news
25 de August de 2026
Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
On August 25, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of a Collaborative Patent Application Examination Project in … Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
19 de August de 2026
Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a … Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology